Navigation Links
New Genetic Test Helps Athletes Maximize Performance, Identify Undiagnosed Risk Factors

RICHMOND, Va., April 27, 2011 /PRNewswire/ -- It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.  It can even save a life. American International Biotechnology Services (AIBioTech) today announced the launch of Sports X Factor, a test kit that provides athletes and parents of young sports competitors a wealth of information about their athletic strengths, potential health hazards and guidance for workout programs that are tailored to maximize performance.

The $200 test, which is available to the general public at, enables individuals to understand how to maximize strength, power, and endurance.  Even more important, the test can identify the length of time an athlete needs to rest after experiencing a concussion, his or her chances for negative results including cardiac risk factors and various other hazards. Sports X Factor identifies increased risks of developing health conditions such as the kind of undiagnosed heart conditions that have felled young athletes during or immediately after strenuous workouts or competitions.  Various options available with the test equip users to make better decisions about their exercise routines and to order customized workout programs based on their genetic results.

"While all the genes in this kit have been studied in the past, these tests have not been widely available to the public primarily because of cost," said Bill Miller, CEO of AIBioTech.  "We have found an accurate and affordable way to make these tests available to athletes of all ages so they can maximize their potential while greatly reducing the risk of injury and even death."

With spring sports getting underway and summer athletics around the corner, the test is especially beneficial if applied to children.  As parents and kids embark on competitive sports, the results could shape decisions parents, coaches and trainers make about which sports are most appropriate for each specific child, the best methods of training and the potential for injury or life threatening conditions.  Miller referred to this as "…understanding the athlete from the inside out."  

AIBioTech developed the test after two years of analysis of genetic information gleaned from several Genetic research projects.  The company's goal was to create a simple diagnostic tool that parents and athletes could use to make informed decisions about participation in sports.  The recent sudden deaths of several gifted young athletes compelled the company's decision to bring the product to market at this time.

About AIBioTech

AIBioTech provides the next generation in DNA based genetic testing services bringing experience derived after performing almost 20 years of research and development services in the biotechnology field. AIBioTech is one of the world's most comprehensive Contract Research Organizations, and has developed customized solutions in the field of biologics and specialty diagnostics. AIBioTech's expertise in applied genetics, molecular biology, and human genomics has led the way into the next generation of sports science with the introduction of Sports X Factor.

AIBiotech operates under CLIA, or AABB accreditations for laboratory testing subject to regulatory oversight.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Winner Baruch Blumberg, Viral Genetics Advisor, Dies at 85
2. Reportlinker Adds Cytogenetics - Technologies, Markets and Companies
3. Ambry Genetics is First Authorized Customer Service Provider in New Ion Torrent CSP Program
4. Signal Genetics and Pronto Diagnostics Announce Distribution Agreement
5. Interleukin Genetics Reports Fourth Quarter and Year End 2010 Financial Results
6. First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU
7. SG Biofuels Advances Jatropha Biotech Platform with Application of Genetic Markers to Reference Genome
8. Scientists from Toronto and Helsinki discover genetic abnormalities after creation of stem cells
9. WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
10. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
11. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):